Navigation Links
Licensing Strategies of Large Pharmaceutical Companies - Weak R&D Pipelines and the Patent Cliff Stimulate In-Licensing Activity
Date:9/6/2011

7.14.2 Licensing Agreements – AstraZeneca 108

7.14.3 By Value 109

7.14.4 By Type 111

7.14.5 By Geography 112

7.14.6 By Therapy Area 113

7.14.7 By Phase 114

7.15 Astellas 115

7.15.1 Overview 115

7.15.2 Licensing Agreements – Astellas 115

7.15.3 By Value 116

7.15.4 By Type 118

7.15.5 By Geography 119

7.15.6 By Therapy Area 120

7.15.7 By Phase 121

7.16 Daiichi-Sankyo 122

7.16.1 Overview 122

7.16.2 Licensing Agreements – Daiichi Sankyo 122

7.16.3 By Value 123

7.16.4 By Type 124

7.16.5 By Geography 125

7.16.6 By Therapy Area 126

7.16.7 By Phase 127

7.17 Teva Pharma 128

7.17.1 Overview 128

7.17.2 Licensing Agreements – Teva 128

7.17.3 By Value 129

7.17.4 By Geography 132

7.17.5 By Therapy Area 132

7.17.6 By Phase 133

7.18 Eisai 134

7.18.1 Overview 134

7.18.2 Licensing Agreements – Eisai 134

7.18.3 By Value 135

7.18.4 By Type 136

7.18.5 By Geography 137

7.18.6 By Therapy Area 138

7.18.7 By Phase 139

7.19 Baxter 140

7.19.1 Overview 140

7.19.2 Licensing Agreements – Baxter 140

7.19.3 By Value 141

7.19.4 By Type 142

7.19.5 By Therapy Area 143

7.20 Amgen 144

7.20.1 Overview 144

7.20.2 Licensing Agreements – Amgen 144

7.20.3 By Value 145

7.20.4 By Geography 146

7.20.5 By Therapy Area 147

7.20.6 By Phase 148

8 Licensing Strategies In Large Pharmaceutical Companies – Appendix 149

8.1 Market Definitions 149

8.2 Abbreviations 149

8.3 Research Methodology 149

8.3.1 Coverage 150

8.3.2 Secondary Research 150

8.3.3 Primary Research 150

8.3.4 Expert Panel Validation 151

8.4 Section Wise Methodology 151

8.4.1 Trends in In-licen
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Beckman Coulter Announces Licensing Agreements for Molecular Tests with National University of Ireland, Galway
2. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
3. Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University
4. Lilly and TransPharma Medical Announce Licensing and Development Agreement
5. Genzyme and Isis Complete Licensing of Mipomersen
6. MabVax Therapeutics Closes Two Licensing Agreements With Sloan-Kettering Institute for Cancer Research
7. Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement
8. CEL-SCI Announces Expansion of Exclusive Licensing Agreement for Cancer Drug Multikine
9. Ipsogen Expands its US Market Presence Through Licensing Agreement With ARUP Laboratories for the Commercialization of JAK2 Molecular Diagnostic Assays
10. Ironwood Announces Linaclotide European Licensing Agreement with Almirall
11. Addrenex Pharmaceuticals Expands Product Pipeline by Licensing New Drug to Treat Narcolepsy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014 Reportlinker.com announces that a ... its catalogue: PharmaPoint: ... Market Analysis to 2022 ... - India Drug Forecast and Market Analysis ...
(Date:1/15/2014)... 15, 2014  Zafgen, Inc., a leading biopharmaceutical company ... obese patients, today announced initial results from its ... of methionine aminopeptidase 2 (MetAP2), in patients with ... obesity.  These results showed improvements in body weight, ...
(Date:1/14/2014)... HAMILTON, N.J. , Jan. 14, 2014 InformEx, ... buyers and sellers of high-value chemistry, will hold the 30 ... Miami Beach Convention Center from January 21-24. ... than 3,500 attendees from top pharmaceutical, fine chemical and specialty ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
... 11 The American Association of,Health Freedom ... that physician-researchers at the Baromedical Research,Institute and ... Orleans,have reported the successful treatment of chronic ... Brain Research (2007 Oct 12;1174:120-9),are purportedly the ...
... Medical and Research Center and Brigham and Women,s ... the National Heart Lung and Blood,Institute (NHLBI) to ... disease (COPD) ever undertaken. The,multi-institutional study will seek ... COPD, with a long-term,goal of better understanding the ...
Cached Medicine Technology:Researchers Report First Successful Treatment of Chronic Traumatic Brain Injury 2National Jewish, Brigham and Women's Awarded $37 Million to Identify Genes and Other Risk Factors that Influence the Development of COPD 2National Jewish, Brigham and Women's Awarded $37 Million to Identify Genes and Other Risk Factors that Influence the Development of COPD 3
(Date:7/9/2014)... injection drug users in Russia might contribute to ... study, conducted by researchers from Boston University Schools ... St. Petersburg Pavlov State University, sought to discover ... outcomes of a cohort of HIV-positive people with ... were arrested by police were more likely to ...
(Date:7/9/2014)... feelings are personal and subjective, the human brain ... represents emotions across different senses, situations and even ... neuroscientist Adam Anderson. , "We discovered that fine-grained ... an area of the brain associated with emotional ... an individual,s subjective feeling," says Anderson, associate professor ...
(Date:7/9/2014)... 9, 2014 There has been a sharp increase ... Medical Center using MyChart, the online, interactive service that ... with their healthcare providers, schedule appointments, and renew prescriptions. ... actively using MyChart each year increased five-fold, ... more than 10-fold, according to a study by ...
(Date:7/9/2014)... around the world have been linked to an ... from the National Institute for Mathematical and Biological ... also contribute. , In a series of ... severe hemorrhage of internal organs in frogs, could ... if they are exposed to the virus every ...
(Date:7/9/2014)... a reputation for being highly toxic, but when used in ... found to offer potential health benefits in a range of ... new compound (AP39), designed and made at the University of ... delivery of very small amounts of the substance to the ... Exeter have already found that the compound protects mitochondria ...
Breaking Medicine News(10 mins):Health News:BU researchers relate arrests with HIV risk environment 2Health News:Study cracks how the brain processes emotions 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 3Health News:Study predicts ranavirus as potential new culprit in amphibian extinctions 2Health News:Rotten egg gas holds key to healthcare therapies 2
... August 16, 2011 Seattle Children,s Research Institute ... million grant from the Bill & Melinda Gates ... respiratory support device, called Seattle Children,s Positive Airway ... affordable and simple Bubble Continuous Positive Airway Pressure ...
... Italy, August 16, 2011 Facial expressions convey strong ... interpret these cues is crucial in social interaction. This ... and neurological disorders, such as social anxiety or Korsakoff,s ... stress disorder (PTSD) is also characterized by changes in ...
... 16 (HealthDay News) -- Many women in the United States ... due to dangerous ingredients, a new study indicates. Pai ... which are banned in the United States because they increase ... U.S. Food and Drug Administration announced a recall of Pai ...
... exercise routine means being able to overcome the obstacles ... the confidence that you can do it, researchers report. ... abilities increase this "situation-specific self-confidence," a quality the researchers ... self-efficacy to every single health behavior you can think ...
... 15 (HealthDay News) -- You might want to take a ... researchers report that alcohol hinders the restorative functions of sleep. ... students, appear online and in the November print issue of ... Booze,s effect on sleep appears linked to a disruption ...
... , MONDAY, Aug. 15 (HealthDay News) -- ,Just 15 ... death by 14 percent and increase your life expectancy by three ... to do at least 150 minutes, or a total of 1.5 ... finds that doing even half that -- 15 minutes daily is ...
Cached Medicine News:Health News:Seattle Children's lands major funding with hopes of saving thousands of infant lives 2Health News:Seattle Children's lands major funding with hopes of saving thousands of infant lives 3Health News:Reduced recognition of fear and sadness in post-traumatic stress disorder 2Health News:U.S. Women Using Dangerous Weight-Loss Pill 2 Years After Recall 2Health News:Want to keep your exercise resolutions? New research offers pointers 2Health News:Want to keep your exercise resolutions? New research offers pointers 3Health News:More Evidence That Alcohol Hinders Good Sleep 2Health News:A Little Exercise Goes a Long Way to Cut Disease, Death Risk 2
... a two-level control compatible with popular ... Strips and Roche Micral test strips. ... turbidimetric immunoassays using AU Series, Bayer ... Cobas, Diasorin SPQ Test System, Dimension, ...
... the performance of Abuscreen ONLINE, AxSYM, EMIT, ... methods. This control meets current revised guidelines ... Health Services Administration (SAMSHA). Level 1 is ... analytes below screening cut-off levels (negative threshold ...
... 190 spectrophotometer is ideal for most life ... solutions, our patented* PathCheck sensor technology senses ... microplate well, and normalizes the absorbance value ... is within 5% of the value obtained ...
... This control is intended as a ... testing methods. A new feature is ... CRP. It is compatible with most ... ACS:180, Access, Dimension, Elecsys, Stratus and ...
Medicine Products: